TERT and breast cancer: We assessed the ddPCR analytical sensitivity of detecting urinary mutations in 81 BC cases with available matched tumors and identified urinary TERT promoter mutation(s) in US or UP in 69 of the 71 TERT mutated tumors (analytical sensitivity of 97.2%; 95% CI 90.2–99.7).